Skip to main content
. 2016 Jun 2;7(6):e2240. doi: 10.1038/cddis.2016.151

Figure 3.

Figure 3

Downregulation of cdr2 in brains from post-mortem PD patients. (a) Characteristics of PD patients and age-matched controls, including diagnosis, age, sex, race, and post-mortem delay (PMD; h). (b) Tissue lysates from the SN of post-mortem humans were subjected to immunoblot analysis using anti-cdr2 antibody and anti-HSP70 antibody. After normalization against GAPDH, relative intensity of cdr2 in brains from post-mortem PD patients or age-matched controls. Data are shown as mean±S.D. **P<0.01